Laser Study

The Lowy Medical Research Institute sponsored a pilot study to test subthreshold photothermal treatment in macular telangiectasia type 2. The purpose of this study, which employs a FDA approved laser system, is to induce a “healing” response in the treated portion of the macula. Participants were randomized to either treatment or sham (placebo) procedure, in one eye.  The participants were followed for one year with a total of six visits.

The MacTel Laser Study is registered with clinicaltrials.gov, study ID NCT03321916

This study was conducted at the Medical College of Wisconsin. The Laser Study is completed.